Creso Pharma Limited (ASX: CPH) requests back-to-back trading halts be placed on the Company’s securities pursuant to Listing Rule 17.1 whilst the Company considers, plans and executes a capital raising. The Company requests the securities remain in pre-open until the completion and announcement of the aforementioned capital raising or the commencement of trade on Wednesday, 7 October 2020. The Company is not aware of any reason why the trading halt should not be granted. This request has been authorised by the Chairman of Creso Pharma Limited.
CPH Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held
